Financials NEURONES

Equities

NRO

FR0004050250

IT Services & Consulting

Market Closed - Euronext Paris 11:35:00 2024-04-26 EDT 5-day change 1st Jan Change
44.7 EUR -0.45% Intraday chart for NEURONES -4.39% +2.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Capitalization 1 459 500.3 566.7 920.3 950.8 1,085 1,085
Enterprise Value (EV) 1 284.5 282 334 655.7 679 1,062 790.8
P/E ratio 17.7 x 16.2 x 18.4 x 24.5 x 21.6 x 21.6 x 19.9 x
Yield 0.32% 0.97% 0.85% 2.63% 2.55% 2.57% 2.68%
Capitalization / Revenue 0.94 x 0.98 x 1.08 x 1.59 x 1.43 x 1.43 x 1.37 x
EV / Revenue 0.58 x 0.55 x 0.64 x 1.13 x 1.02 x 1.43 x 1 x
EV / EBITDA 5.3 x 4.56 x 5.57 x 8.6 x 7.59 x 11.5 x 8.08 x
EV / FCF 11 x 6 x 5.56 x 12.9 x 15.3 x 20.6 x -
FCF Yield 9.07% 16.7% 18% 7.74% 6.53% 4.86% -
Price to Book 1.72 x 1.68 x 1.76 x 2.95 x 2.87 x 3.04 x 2.84 x
Nbr of stocks (in thousands) 24,286 24,286 24,218 24,218 24,224 24,272 24,272
Reference price 2 18.90 20.60 23.40 38.00 39.25 44.70 44.70
Announcement Date 19-03-13 20-03-04 21-02-10 22-02-09 23-02-08 24-03-06 -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net sales 1 490.1 510.1 524.5 579.9 665.4 741.2 793.1
EBITDA 1 53.69 61.79 60 76.28 89.44 92.61 97.91
EBIT 1 46 53.7 51.9 61.6 72.9 75.9 79.39
Operating Margin 9.39% 10.53% 9.9% 10.62% 10.96% 10.24% 10.01%
Earnings before Tax (EBT) 1 44 53.8 53.6 61.7 72.86 80.76 -
Net income 1 26 30.8 30.9 37.7 44.3 49.4 54.57
Net margin 5.31% 6.04% 5.89% 6.5% 6.66% 6.66% 6.88%
EPS 2 1.070 1.270 1.270 1.550 1.820 2.030 2.247
Free Cash Flow 1 25.8 47 60.1 50.76 44.36 51.6 -
FCF margin 5.26% 9.21% 11.46% 8.75% 6.67% 6.96% -
FCF Conversion (EBITDA) 48.06% 76.06% 100.16% 66.55% 49.6% 55.72% -
FCF Conversion (Net income) 99.23% 152.6% 194.49% 134.65% 100.14% 104.45% -
Dividend per Share 2 0.0600 0.2000 0.2000 1.000 1.000 1.150 1.200
Announcement Date 19-03-13 20-03-04 21-02-10 22-02-09 23-02-08 24-03-06 -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - - - -
Net Cash position 1 175 218 233 265 272 258 294
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 25.8 47 60.1 50.8 44.4 51.6 -
ROE (net income / shareholders' equity) 10.2% 11.4% 9.97% 11.9% 13.8% 15.3% 14.8%
ROA (Net income/ Total Assets) - - - - 7.47% - -
Assets 1 - - - - 593.3 - -
Book Value Per Share 2 11.00 12.20 13.30 12.90 13.70 14.70 15.80
Cash Flow per Share 2 1.280 2.520 2.770 2.360 2.660 2.970 3.050
Capex 6.95 7.89 - - 10.6 - -
Capex / Sales 1.42% 1.55% - - 1.59% - -
Announcement Date 19-03-13 20-03-04 21-02-10 22-02-09 23-02-08 24-03-06 -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
44.7 EUR
Average target price
50 EUR
Spread / Average Target
+11.86%
Consensus

Annual profits - Rate of surprise